Kansas Health Center COVID-19 Survey Summary Report

Latest data from October 8, 2021

Number of Health Center respondents = 15 (79% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 3,342
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) 31.09%
Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 502
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen) 24.35%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, antigen)2 Patients Tested Positive, Virus Detection (PCR, antigen)2
White, Non-Hispanic/Latino Patients 63.14% 69.92%
White, Hispanic/Latino Patients 13.32% 10.76%
Black/African American, Non-Hispanic/Latino Patients 6.01% 6.57%
Black/African American, Hispanic/Latino Patients 0.21% 0.00%
Asian Patients3 0.60% 0.00%
American Indian/Alaska Native Patients3 4.73% 0.40%
Native Hawaiian/Other Pacific Islander Patients3 0.30% 0.20%
Patients with More than one race3 0.45% 0.60%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 2.87% 3.98%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 1.80% 1.39%
Unreported/Refused to Report Race and Ethnicity 6.58% 6.18%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 558
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 46.93%
COVID-19 Immunization Series Completed 734
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 38.63%
COVID-19 Immunization Series Additional 209
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 18.18%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 49.64% 53.68% 73.21%
White, Hispanic/Latino Patients 18.64% 17.44% 4.31%
Black/African American, Non-Hispanic/Latino Patients 5.38% 6.13% 4.78%
Black/African American, Hispanic/Latino Patients 0.36% 0.41% 0.00%
Asian Patients3 0.54% 0.27% 1.44%
American Indian/Alaska Native Patients3 2.69% 2.72% 4.78%
Native Hawaiian/Other Pacific Islander Patients3 0.36% 0.68% 0.00%
Patients with More than one race3 0.72% 1.23% 0.48%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 15.23% 4.90% 0.48%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 1.97% 1.50% 0.00%
Unreported/Refused to Report Race and Ethnicity 4.48% 11.04% 10.53%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)

Metrics Value
Less Than 1 Hour 26.67%
1 to 24 Hours 53.33%
More Than 24 Hours 13.33%
N/A 6.67%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 0.00%
Staffing to administer the vaccine 13.33%
Vaccine confidence 40.00%
Vaccine storage capacity 0.00%
Vaccine supply 0.00%
Other 13.33%
None 40.00%

Operations and Staff

Metrics Value
COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program 26.67%
Average Percent of Health Center Visits Conducted Virtually 13.00%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 33.33%
Number of Mobile Van Sites 1
Number of Pop-up Clinics 15
Number of School-Based Vaccination Sites 0

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 6.67%
Refer patients to another organization that provides monoclonal antibody therapies 53.33%
None 40.00%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 6.67%
Patient awareness/education 0.00%
Staffing capacity 6.67%
Therapy administration/onsite logistics 20.00%
Other 6.67%
None 60.00%

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

Date Last Reviewed:  October 2021